Cargando…
CD137 agonist induces gastric cancer cell apoptosis by enhancing the functions of CD8(+) T cells via NF-κB signaling
BACKGROUND: CD137 is a target for tumor immunotherapy. However, the role of CD137 in gastric cancer (GC), especially in inducing GC cell apoptosis, has not been studied. METHODS: Foxp3(+) and CD8(+) T cells in GCs were investigated using immunohistochemistry (IHC). CD137 expression in GCs was detect...
Autores principales: | Hu, Ben-Shun, Tang, Tian, Jia, Jun-Li, Xie, Bi-Chen, Wu, Tie-Long, Sheng, Ying-Yue, Xue, Yu-Zheng, Tang, Hua-Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7576737/ https://www.ncbi.nlm.nih.gov/pubmed/33093811 http://dx.doi.org/10.1186/s12935-020-01605-0 |
Ejemplares similares
-
Soluble CD137 as a dynamic biomarker to monitor agonist CD137 immunotherapies
por: Glez-Vaz, Javier, et al.
Publicado: (2022) -
Correction: Soluble CD137 as a dynamic biomarker to monitor agonist CD137 immunotherapies
Publicado: (2023) -
Celastrol induces apoptosis of gastric cancer cells by miR-146a inhibition of NF-κB activity
por: Sha, Min, et al.
Publicado: (2013) -
Tumor-infiltrating CD4(+) T cells in patients with gastric cancer
por: Yuan, Long, et al.
Publicado: (2017) -
CD137 Signaling Promotes Endothelial Apoptosis by Inhibiting Nrf2 Pathway, and Upregulating NF-κB Pathway
por: Geng, Tianxin, et al.
Publicado: (2020)